下肢骨肿瘤间置异体骨重建的长期临床结局
结果显示骨不连发生率为16%,异体骨骨折为19%,机械性失败5年、10年、15年累积发生率分别为9%、14%、21%,提示需持续关注机械并发症风险。
要点
- 间置异体骨重建后骨不连发生率16%,与单纯髓内钉固定和非桥接钢板固定相关。
- 异体骨骨折发生率19%,其中52%发生在5年内,32%在5至10年,16%在10年后。
- 机械性失败5年、10年、15年累积发生率分别为9%、14%、21%,风险持续存在。
核心结论
- 间置异体骨重建是可接受的重建选择,但存在相当且持续的机械并发症风险。
主要发现
- 骨不连发生21例(16%),中位时间16个月,与单纯髓内钉固定(p < 0.01)和非桥接钢板固定(p = 0.03)相关。
- 异体骨骨折发生25例(19%),中位时间42个月(范围4天至21.9年),其中52%在5年内,32%在5至10年,16%在10年后。
- 以机械性失败为终点,重建失败5年、10年、15年累积发生率分别为9%、14%、21%。
关键数值与推荐
- 骨不连发生率16%,异体骨骨折发生率19%,机械性失败5年、10年、15年累积发生率分别为9%、14%、21%。
临床怎么用
- 用于下肢骨肿瘤切除后间置重建时,应告知患者长期机械并发症风险,并定期随访监测骨不连和异体骨骨折。
局限性
- 回顾性研究设计,证据等级为治疗性IV级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Improved survival rates for patients with primary bone tumors of the extremities have increased the demand for reliable and durable reconstruction techniques. Some authors have stated that, after successful ingrowth, allografts are a durable long-term solution. This hypothesis is largely based on small studies with short-to-midterm follow-up. In order to determine the durability of intercalary allograft reconstructions in the lower extremities, we evaluated the long-term clinical outcomes at a minimum of 10 years. METHODS: All patients who received an intercalary allograft reconstruction in a lower extremity between 1980 and 2006 were included in this retrospective multicenter cohort study. One hundred and thirty-one patients with a median age of 19 years were included. Eighty-nine (68%) had a femoral reconstruction, and 42 (32%) had a tibial reconstruction. The most prevalent diagnoses were osteosarcoma (55%), Ewing sarcoma (17%), and chondrosarcoma (12%). The median follow-up was 14 years. A competing risk model was employed to estimate the cumulative incidences of mechanical failure and infection. Patient mortality or progression of the disease was used as a competing event. RESULTS: Nonunion occurred in 21 reconstructions (16%), after a median of 16 months, and was associated with intramedullary nail-only fixation (p < 0.01) and fixation with nonbridging plate(s) (p = 0.03). Allograft fracture occurred in 25 reconstructions (19%) after a median of 42 months (range, 4 days to 21.9 years). Thirteen (52%) of the allograft fractures occurred within 5 years; 8 (32%), between 5 and 10 years; and 4 (16%), at >10 years. With failure for mechanical reasons as the end point, the cumulative incidences of reconstruction failure at 5, 10, and 15 years were 9%, 14%, and 21%, respectively. CONCLUSIONS: Intercalary allograft reconstruction is an acceptable reconstructive option, mainly because of the absence of superior alternatives with a known track record. However, a considerable and continuing risk of mechanical complications should be taken into account. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
引用
- Sanders PTJ, Spierings JF, Albergo JI, et al. Long-Term Clinical Outcomes of Intercalary Allograft Reconstruction for Lower-Extremity Bone Tumors. J Bone Joint Surg Am. 2020. PMID: 32265356. doi:10.2106/JBJS.18.00893
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。